Our current work fills in this gap and identifies the importance of NKX2-2 as a tool of EWS/FLI in repressing salient mesenchymal characteristics of Ewing sarcoma cells, first displayed by unbiased transcriptional profiling. The gene discussed is FLII; the disease is Ewing sarcoma.